April 27, 2012
Dainippon Sumitomo Pharma (DSP) announced on April 25 that it has completed its acquisition of Boston Biomedical Inc. (BBI), a US drug discovery venture that focuses on R&D in the field of oncology. BBI became DSP’s wholly-owned subsidiary on April...read more